SAB Biotherapeutics, Inc. - SABS
About Gravity Analytica
Recent News
- 02.12.2025 - February 12, 2025 10:00 AM EST - February 12, 2025 10:30 AM EST : Oppenheimer 35th Annual Healthcare Life Sciences Conference
- 02.06.2025 - February 6, 2025 2:00 PM EST - June 26, 2025 2:25 PM EDT : Guggenheim SMID Cap Biotech Conference
- 01.31.2025 - SAB BIO to Participate in Upcoming Investor Conferences
- 01.28.2025 - SAB BIO R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Potentially Disease-Modifying T1D Therapy
- 01.28.2025 - SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
- 01.23.2025 - SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy
- 09.13.2024 - SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
- 09.09.2024 - SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting
- 09.06.2024 - Leland Gershell, MD, PhD